Redmile Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-86,782
| Closed | -$20.5M | – | 78 |
|
|
2023
Q4 | $20.5M | Buy |
86,782
+20,400
| +31% | +$4.82M | 0.73% | 38 |
|
|
2023
Q3 | $13M | Sell |
66,382
-47,969
| -42% | -$9.4M | 0.62% | 37 |
|
|
2023
Q2 | $24M | Sell |
114,351
-977
| -0.8% | -$205K | 0.92% | 33 |
|
|
2023
Q1 | $23.3M | Buy |
+115,328
| New | +$23.3M | 1.01% | 40 |
|
|
2021
Q3 | – | Sell |
-108,374
| Closed | -$40.1M | – | 79 |
|
|
2021
Q2 | $40.1M | Sell |
108,374
-58,305
| -35% | -$21.6M | 0.59% | 46 |
|
|
2021
Q1 | $48.3M | Buy |
+166,679
| New | +$48.3M | 0.68% | 43 |
|
|
2017
Q2 | – | Sell |
-121,307
| Closed | -$10.9M | – | 63 |
|
|
2017
Q1 | $10.9M | Sell |
121,307
-125,800
| -51% | -$11.3M | 0.71% | 46 |
|
|
2016
Q4 | $18.8M | Buy |
247,107
+120,001
| +94% | +$9.14M | 1.62% | 23 |
|
|
2016
Q3 | $10.6M | Sell |
127,106
-4,500
| -3% | -$375K | 0.84% | 31 |
|
|
2016
Q2 | $10.9M | Buy |
131,606
+21,800
| +20% | +$1.8M | 1.04% | 30 |
|
|
2016
Q1 | $8.34M | Sell |
109,806
-12,594
| -10% | -$956K | 0.85% | 29 |
|
|
2015
Q4 | $9.84M | Buy |
+122,400
| New | +$9.84M | 0.74% | 31 |
|